铼羰基化合物的制备及其在小鼠体内的生物分布

    Synthesis and Biodistribution of 188ReTricarbonyl Complexes

    • 摘要: 选择三齿配基L1,L2,L3及L4(L1 =组氨酸, L2 =次氮基三乙酸,L3= 2-吡啶甲基胺N, N-二乙酸,L4 =二(2-吡啶甲基)-胺)作为双功能螯合剂可以连接受体、多肽、蛋白等靶向分子,用于设计合成新的以188Re(CO)3+为核心的放射性药物。标记实验表明,4个配基的浓度在1×10-5~1×10-4mol/L,反应时间为30min时,放射化学产率大于90%,用HPLC分离后,放射化学纯度大于95%。电泳实验表明,配合物显示不同的价态。稳定性实验表明,4种配合物在体外稳定,24h几乎不发生分解。组氨酸与半胱氨酸竞争实验说明,24h内4个配合物很难发生配基与半胱氨酸的交换反应,而在组氨酸溶液中,除L2形成的配合物相对来说不稳定外,其它3个较稳定。是否在体内有很高的稳定性,还需实验进一步证实。小鼠动物试验表明,4个配合物均能较快地从血液和多数组织器官中清除,主要在肝和肾中浓集,是较理想的双功能螯合剂。

       

      Abstract: Radiolabeling of biologically active molecules with the fac188Re(CO)3(H2O)3+ unit has been of primary interest in recent years. Therefore, the tridentate ligands L1~L4 (L1 =histidine, L2 = nitrilotriacetic, L3 = 2-picolylamine-N,N-diacetic acid, L4 = bis(2-pyridymethy)amine)were evaluated in radiochemical reactions with the fac188Re(CO)3(H2O)3+. These reactions yielded the radioactive building blocks fac188Re(CO)3L (L = L1~L4), which were identified by HPLC. Tricarbonyl complexes, with lg P values ranging from -2.23 to 2.18, were obtained in yields higher than 90% using ligand concentrations within the 1×10-5~1×10-4 mol/L range. Competition studies with cysteine and histidine revealed high stability for all of these radioactive complexes, and biodistribution studies in mice indicated a fast rate of blood clearance and high rate of total radioactivity excretion occurring primarily through the renalurinary pathway. In summary, complexes (L1~L4) are potent chelators for the future functionalization of biomolecules.

       

    /

    返回文章
    返回